ClinConnect ClinConnect Logo
Search / Trial NCT06998680

6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair

Launched by VITA GREEN PHARMACEUTICAL (H.K.) LTD. · May 30, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of Chinese herbal treatments on hair loss and gray hair over a period of six months. Researchers will enroll 152 adults, aged 18 to 60, who experience hair loss, including those with gray hair. Participants will be randomly divided into four groups, and each group will receive a combination of oral capsules and a hair tonic to use as directed. Throughout the trial, participants will have three in-person visits where their hair growth will be assessed through tests and photographs. Additionally, 10 participants from each group who have gray hair will have special assessments to see if there are any changes in their hair color.

To be eligible for the trial, participants must understand the study's purpose and procedures and sign an informed consent form. They should have a minimum hair length of 5 cm and meet specific criteria related to hair loss patterns. Women must also have a certain classification of hair thinning, while men must meet different standards. It's important to note that individuals who are pregnant, breastfeeding, or have certain medical conditions that cause hair loss will not be able to participate. Overall, this study aims to gather important information about the potential benefits of these herbal treatments for managing hair loss and gray hair.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Participants must sign the informed consent form prior to enrollment and fully understand the study's purpose, procedures, and potential adverse events.
  • 2. Adults aged 18 to 60 years, both male and female; each group must include no less than 50% female participants.
  • 3. Hair length must be greater than 5 cm.
  • 4. Women must meet the Savin scale classification between grades 1-3 to II.
  • 5. Men must meet the Norwood-Hamilton classification between stages II and VI.
  • 6. At least 10 participants in each group must have gray hair, with a minimum of 5 gray hairs within a 1 cm × 4 cm area of the scalp.
  • 7. Participants must not have undergone any special hair treatments-such as dyeing, perming, or styling-within the past two months.
  • Exclusion Criteria:
  • 1. Pregnant or breastfeeding women, or individuals planning to conceive in the near future.
  • 2. Individuals with medical conditions causing hair loss, such as refractory alopecia areata, inflammatory scarring alopecia, or psoriatic alopecia; or those diagnosed with other scalp or hair disorders.
  • 3. Individuals with diagnosed psychiatric or psychological disorders, or those with long-term sleep disturbances or emotional regulation issues.
  • 4. Use of anti-hair loss cosmetics or other hair growth-promoting products within the past 3 months.
  • 5. Use of any systemic or topical medications known to affect hair growth within the past 6 months.
  • 6. History of hair transplantation.
  • 7. Curly hair.
  • 8. Individuals with highly sensitive constitutions.
  • 9. Individuals diagnosed with severe anemia or abnormal liver/kidney function during physical examination.
  • 10. Participation in any other clinical trials involving the test area within the past 2 months.
  • 11. Any other conditions deemed unsuitable for participation by the clinical investigators.

About Vita Green Pharmaceutical (H.K.) Ltd.

Vita Green Pharmaceutical (H.K.) Ltd. is a leading healthcare company based in Hong Kong, specializing in the research, development, and manufacturing of high-quality herbal and nutritional products. With a strong commitment to innovation and excellence, the company aims to enhance the well-being of individuals through evidence-based solutions. Vita Green's extensive portfolio includes dietary supplements, functional foods, and traditional herbal remedies, all formulated to support various health needs. The company is dedicated to rigorous clinical research and collaboration with healthcare professionals, ensuring that its products meet the highest standards of safety and efficacy.

Locations

Xiangtan, Hunan, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported